The treatment increased the NRF2 gene expression in the hippocampus of the DM1 mice by modulating the brain-derived neurotrophic factor (BDNF) levels, which regulates Nrf2 nuclear translocation [103]. Here, BDNF is linked to myotonic dystrophy type 1.